Michelle Bestic et al.
Journal of clinical pharmacology, 49(2), 130-137 (2008-11-14)
Fomepizole, 4-methylpyrazole (4-MP), is a competitive antagonist of alcohol dehydrogenase with a binding affinity >8000 times that of ethanol. The drug is currently labeled by the United States Food and Drug Administration for the treatment of adult patients with known